Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M53,375Revenue $M137,609Net Margin (%)1.0Z-Score4.4
Enterprise Value $M59,254EPS $5.4Operating Margin %1.6F-Score6
P/E(ttm))31.2Cash Flow Per Share $8.8Pre-tax Margin (%)1.4Higher ROA y-yY
Price/Book5.910-y EBITDA Growth Rate %23.8Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.35-y EBITDA Growth Rate %16.3Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow10.9y-y EBITDA Growth Rate %30.7ROA % (ttm)3.5Higher Current Ratio y-yN
Dividend Yield %0.4Insider Buy (3m)0ROE % (ttm)19.7Less Shares Outstanding y-yN
Payout Ratio %13.0Shares Outstanding M233ROI % (ttm)10.5Gross Margin Increase y-yY

Gurus Latest Trades with MCK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MCKLeon Cooperman 2014-12-31 Add0.22%$185.02 - $212.78
($203.25)
$ 229.2311%Add 9.66%715,203
MCKMario Gabelli 2014-12-31 Add$185.02 - $212.78
($203.24)
$ 229.2311%Add 24.57%17,490
MCKKen Fisher 2014-12-31 Buy $185.02 - $212.78
($203.24)
$ 229.2311%New holding967
MCKVanguard Health Care Fund 2014-09-30 Reduce-0.12%$186.58 - $199.63
($192.57)
$ 229.2316%Reduce -3.66%6,342,800
MCKJoel Greenblatt 2014-09-30 Sold Out -0.05%$186.58 - $199.63
($192.57)
$ 229.2316%Sold Out0
MCKVanguard Health Care Fund 2014-06-30 Reduce-0.37%$164.68 - $191.63
($177.78)
$ 229.2322%Reduce -10.34%6,584,000
MCKJoel Greenblatt 2014-06-30 Reduce-0.07%$164.68 - $191.63
($177.78)
$ 229.2322%Reduce -54.47%20,104
MCKMario Gabelli 2014-06-30 Add$164.68 - $191.63
($177.78)
$ 229.2322%Add 26.39%14,560
MCKJoel Greenblatt 2014-03-31 Add0.06%$160.16 - $185.35
($174.27)
$ 229.2324%Add 106.75%44,157
MCKVanguard Health Care Fund 2014-03-31 Reduce-0.05%$160.16 - $185.35
($174.74)
$ 229.2324%Reduce -1.43%7,343,200
MCKLeon Cooperman 2014-03-31 Add0.04%$160.16 - $185.35
($174.74)
$ 229.2324%Add 2.52%710,982
MCKMario Gabelli 2014-03-31 Buy 0.01%$160.16 - $185.35
($174.27)
$ 229.2324%New holding11,520
MCKVanguard Health Care Fund 2013-12-31 Reduce-0.43%$129.57 - $165.89
($153.82)
$ 229.2333%Reduce -11.73%7,449,500
MCKJoel Greenblatt 2013-12-31 Reduce-0.07%$129.57 - $165.89
($153.82)
$ 229.2333%Reduce -45.81%21,358
MCKMario Gabelli 2013-12-31 Sold Out $129.57 - $165.89
($153.82)
$ 229.2333%Sold Out0
MCKJoel Greenblatt 2013-09-30 Add0.09%$114.28 - $132.01
($122.87)
$ 229.2346%Add 130.72%39,414
MCKLeon Cooperman 2013-09-30 Add0.04%$114.28 - $132.01
($122.85)
$ 229.2346%Add 2.86%691,382
MCKVanguard Health Care Fund 2013-09-30 Reduce-0.04%$114.28 - $132.01
($122.85)
$ 229.2346%Reduce -1.18%8,439,000
MCKLeon Cooperman 2013-06-30 Buy 1.2%$104.18 - $118.41
($111.3)
$ 229.2351%New holding672,182
MCKJoel Greenblatt 2013-06-30 Buy 0.08%$104.18 - $118.41
($111.3)
$ 229.2351%New holding17,083
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MCK is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


MCK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Spratt Randall NEVP, CTO & CIO 2015-02-17Sell44,523$2250.04view
Spratt Randall NEVP, CTO & CIO 2015-02-12Sell7,477$2250.04view
REES NIGEL AVice President & Controller, 10% Owner 2015-02-10Sell9,000$220.422.12view
IRBY ALTON F IIIDirector 2015-02-10Sell5,000$220.761.96view
HAMMERGREN JOHN HChairman, President & CEO 2015-01-28Sell64,521$219.522.54view
Tyler Brian ScottEVP, Corp Strategy & Bus. Dev. 2015-01-26Sell5,431$216.623.91view
HAMMERGREN JOHN HChairman, President & CEO 2015-01-26Sell35,479$219.072.75view
HAMMERGREN JOHN HChairman, President & CEO 2015-01-07Sell77,100$2145.18view
HAMMERGREN JOHN HChairman, President & CEO 2014-12-19Sell10,700$2145.18view
HAMMERGREN JOHN HChairman, President & CEO 2014-12-08Sell12,200$214.015.18view

Press Releases about MCK :

    Quarterly/Annual Reports about MCK:

    News about MCK:

    Articles On GuruFocus.com
    Why Hedge Funds Are Betting On AmerisourceBergen Apr 10 2015 
    Rite Aid – What To Expect From Q4 And Full Fiscal Earnings Report Tomorrow Apr 07 2015 
    Larry Robbins' Top Growth Stocks Mar 25 2015 
    Leon Cooperman's Top Growth Stocks Mar 22 2015 
    Rite Aid Corporation is a Buy Feb 19 2015 
    Manson Creek Terminates Option on Uptown Gold Property, NWT Dec 22 2014 
    Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
    A Few Reasons Why McKesson Could Be a Good Investment Dec 11 2014 
    AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
    CPSI: A Predictable And Undervalued Small Cap Dec 05 2014 

    More From Other Websites
    Just One-Third Of Hospitals IT-Ready For Population Health Apr 13 2015
    Why Hedge Funds Are Betting On AmerisourceBergen Apr 10 2015
    McKesson at HIMSS15: Focus Ahead on Streamlining the Transition to Value-Based Care Apr 10 2015
    McKesson Introduces Conserus™ to Help Optimize Imaging Workflows and Clinical Effectiveness Apr 09 2015
    McKesson Provides Illinois Radiology Group with Revenue Cycle, Financial Management Assistance Apr 09 2015
    McKesson Helps Stabilize Billing for Michigan Radiology Group Apr 09 2015
    Rite Aid (RAD) Earnings Report: Q4 2015 Conference Call Transcript Apr 08 2015
    Milwaukee Clinical Laboratory Chooses McKesson Apr 08 2015
    Higher prescription sales help Rite Aid beat profit estimates Apr 08 2015
    UBS Makes Changes to Equity Focus List for April Apr 02 2015
    Lightning Round: Be careful-this lurks everywhere Apr 01 2015
    Finding a great growth story in drug distribution Apr 01 2015
    McKesson Stock: 3 Reasons Why It Is a Top Choice for Growth Investors - Tale of the Tape Mar 31 2015
    McKesson Provides Illinois Radiology Group with Revenue Cycle, Financial Management Assistance Mar 30 2015
    McKesson Helps Stabilize Billing for Michigan Radiology Group Mar 24 2015
    Stocks Off To A Twitchy Start; Netflix, Twitter, Merck Surge Mar 24 2015
    DENTSPLY: Product Portfolio Strong, Currency Woes Remain - Analyst Blog Mar 19 2015
    CONMED: Strong Sell on Dismal Q4 Results, Estimate Revision - Analyst Blog Mar 18 2015
    LabCorp Boosts Specialty Testing with Two New Studies - Analyst Blog Mar 16 2015
    Invacare Cut to Strong Sell on Dismal Q4, Should You Dump? - Analyst Blog Mar 12 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK